ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2474

Psychometric Properties of the Social Appearance Anxiety Scale in Patients with Limited and Diffuse Systemic Sclerosis: Analysis from the Scleroderma Patient-Centered Intervention Network Cohort

Sarah D. Mills1, Shadi Gholizadeh1, Rina S. Fox1, Lisa R. Jewett2,3, Marie-Eve Carrier3, Linda Kwakkenbos2,3, Karen Gottesman4, Scott C. Roesch1,5, Brett D. Thombs2,3, Vanessa L. Malcarne1,5 and SPIN Investigators6, 1SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2McGill University, Montreal, QC, Canada, 3Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada, 4Scleroderma Foundation, Los Angeles, CA, 5Psychology, San Diego State University, San Diego, CA, 6Scleroderma Patient-centered Intervention Network, Montreal, QC, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Anxiety, measure, psychological well-being and systemic sclerosis, Validity

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Psychology/Social Sciences (ARHP)

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Despite the common appearance changes in patients with systemic sclerosis (SSc), and the potential adverse psychosocial impact of such changes, research in this area is limited. This may be, in part, because there are few validated measures evaluating the psychosocial impact of disease-related appearance changes in SSc. Thus, the goal of the present study was two-fold: 1) to evaluate the psychometric properties of the Social Appearance Anxiety Scale (SAAS), a measure that assesses fear of situations in which one’s appearance will be evaluated, in a sample of SSc patients, and 2) to determine if scores from the SAAS can be meaningfully compared across limited and diffuse SSc subtypes.

Methods: The sample included SSc patients (N = 600; 59% limited, 41% diffuse) enrolled in the Scleroderma Patient-centered Intervention Network Cohort. Confirmatory factor analysis (CFA) was used to examine the structural validity of the measure; a one-factor model was hypothesized. Once the model with adequate fit was identified, multiple-group CFA was used to evaluate measurement invariance of the SAAS across limited and diffuse SSc patients. Internal consistency reliability was examined using Cronbach’s coefficient alpha. Convergent validity was examined via Pearson product-moment correlations with the SAAS and a measure of depression, body image dissatisfaction, and two measures of social anxiety.

Results: Based on descriptive fit indices, a one-factor model showed good fit with the data using CFA (Comparative Fit Index [CFI] = 0.91, Standardized Root Mean Residual [SRMR] = 0.04, Root Mean Square Error of Approximation [RMSEA] = 0.12). The multiple-group CFA evaluated configural invariance (i.e., baseline model fitting a one-factor solution for limited and diffuse subtypes), metric invariance (i.e., factor loadings constrained to equivalence across subtypes), and factor variance invariance (i.e., factor loadings and variances constrained to equivalence across subtypes) based on descriptive fit indices (CFI, SRMR, and RMSEA), change in CFI, and the Satorra-Bentler X2 difference test. Results from the multiple-group CFA provided support for the factor variance invariance model, suggesting a one-factor structure with equivalent response patterns and variances across limited and diffuse subtypes. Internal consistency was good for both limited (α  = 0.96) and diffuse (α  = 0.97) groups. Convergent validity was demonstrated via moderate to strong correlations with measures of depression (r = 0.52, p < .01), body image dissatisfaction (r = 0.68, p < .01), and social anxiety (2 measures; r = 0.58 to 0.67, p < .01) in the total sample.

 Conclusion: Overall, results indicate that the one-factor SAAS can be used to assess fear of appearance evaluation among patients with SSc. In addition, scores on the SAAS can be meaningfully compared across limited and diffuse subtypes.


Disclosure: S. D. Mills, None; S. Gholizadeh, None; R. S. Fox, None; L. R. Jewett, None; M. E. Carrier, None; L. Kwakkenbos, None; K. Gottesman, None; S. C. Roesch, None; B. D. Thombs, None; V. L. Malcarne, None; S. Investigators, None.

To cite this abstract in AMA style:

Mills SD, Gholizadeh S, Fox RS, Jewett LR, Carrier ME, Kwakkenbos L, Gottesman K, Roesch SC, Thombs BD, Malcarne VL, Investigators S. Psychometric Properties of the Social Appearance Anxiety Scale in Patients with Limited and Diffuse Systemic Sclerosis: Analysis from the Scleroderma Patient-Centered Intervention Network Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/psychometric-properties-of-the-social-appearance-anxiety-scale-in-patients-with-limited-and-diffuse-systemic-sclerosis-analysis-from-the-scleroderma-patient-centered-intervention-network-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/psychometric-properties-of-the-social-appearance-anxiety-scale-in-patients-with-limited-and-diffuse-systemic-sclerosis-analysis-from-the-scleroderma-patient-centered-intervention-network-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology